Invesco
BBNX

Invesco’s Beta Bionics BBNX Stock Holding History

Invesco’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$195K Sell
19,464
-97,896
-83% -$1.45M ﹤0.01% 3487
2025
Q4 		$3.58M Buy
117,360
+68,640
+141% +$1.83M ﹤0.01% 2392
2025
Q3 		$968K Buy
48,720
+32,424
+199% +$570K ﹤0.01% 2948
2025
Q2 		$237K Sell
16,296
-168
-1% -$2.38K ﹤0.01% 3466
2025
Q1 		$202K Buy
+16,464
New +$307K ﹤0.01% 3509

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco's BBNX Position: Q1 2026 in Review

Invesco reduced its Beta Bionics (BBNX) stake by 83% in Q1 2026, selling an estimated $1.45M and leaving 19,464 shares worth $195K. The position accounts for ﹤0.01% of the portfolio, ranked #3487.

Invesco first reported a position in BBNX in Q1 2025 and has held it in 5 quarters since. The position peaked at $3.58M in Q4 2025. 130 funds tracked by Wall St. Rank hold BBNX as of Q1 2026.

  • Invesco held 19,464 shares of Beta Bionics worth $195K as of Q1 2026.
  • Invesco sold 97,896 Beta Bionics shares in Q1 2026, an estimated $1.45M.
  • Beta Bionics made up ﹤0.01% of Invesco's portfolio in Q1 2026, its #3487 holding.
  • Invesco first reported a position in Beta Bionics in Q1 2025 and has held it in 5 quarters since.
  • Invesco's Beta Bionics position peaked at $3.58M in Q4 2025.
  • 130 funds tracked by Wall St. Rank held Beta Bionics as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.